LOSARTAN POTASSIUM | A076958 | TEVA PHARMACEUTICALS USA INC
Total Spending
$487.6M
Total Claims
33,195,685
Beneficiaries
8,190,862
Avg Cost/Unit
$0.19
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.
27 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Apr 16, 2010 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.